Zucker S - Search Results

1

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.

Sparano JA, Bernardo P, Stephenson P, Gradishar WJ, Ingle JN, Zucker S, Davidson NE. Sparano JA, et al. Among authors: zucker s. J Clin Oncol. 2004 Dec 1;22(23):4683-90. doi: 10.1200/JCO.2004.08.054. J Clin Oncol. 2004. PMID: 15570070 Clinical Trial.

2

Plasma matrix metalloproteinases 7 and 9 in patients with metastatic breast cancer treated with marimastat or placebo: Eastern Cooperative Oncology Group trial E2196.

Zucker S, Wang M, Sparano JA, Gradishar WJ, Ingle JN, Davidson NE; Eastern Cooperative Oncology Group. Zucker S, et al. Clin Breast Cancer. 2006 Feb;6(6):525-9. doi: 10.3816/cbc.2006.n.006. Clin Breast Cancer. 2006. PMID: 16595036 Clinical Trial.

3

Plasma MMPs as surrogates of BAY 12-9566.

Zucker S, Eckhardt SG, Rowinsky EK. Zucker S, et al. J Clin Oncol. 2000 Apr;18(8):1805-6. doi: 10.1200/JCO.2000.18.8.1805. J Clin Oncol. 2000. PMID: 10764446 No abstract available.

4

Warfarin anticoagulation for small-cell lung cancer: evidence against a cytotoxic or anticoagulant mechanism.

Silberberg JM, Zucker S. Silberberg JM, et al. Among authors: zucker s. J Clin Oncol. 1990 Jan;8(1):182-4. doi: 10.1200/JCO.1990.8.1.182. J Clin Oncol. 1990. PMID: 2153191 No abstract available.

5

M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.

Zucker S, Lysik RM, Zarrabi MH, Moll U. Zucker S, et al. Cancer Res. 1993 Jan 1;53(1):140-6. Cancer Res. 1993. PMID: 8416738

6

Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer.

Zucker S, Lysik RM, DiMassimo BI, Zarrabi HM, Moll UM, Grimson R, Tickle SP, Docherty AJ. Zucker S, et al. Cancer. 1995 Aug 15;76(4):700-8. doi: 10.1002/1097-0142(19950815)76:4<700::aid-cncr2820760426>3.0.co;2-5. Cancer. 1995. PMID: 8625169

7

Measurement of matrix metalloproteinases in serum of patients with melanoma: snarled in technical pitfalls.

Zucker S, Cao J. Zucker S, et al. Clin Cancer Res. 2005 Jul 15;11(14):5069-70. doi: 10.1158/1078-0432.CCR-05-0774. Clin Cancer Res. 2005. PMID: 16033818 No abstract available.

8

Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis.

Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, Klein-Szanto AJ. Zucker S, et al. Int J Cancer. 1992 Sep 30;52(3):366-71. doi: 10.1002/ijc.2910520307. Int J Cancer. 1992. PMID: 1399111

9

Type IV collagenase/gelatinase (MMP-2) is not increased in plasma of patients with cancer.

Zucker S, Lysik RM, Zarrabi MH, Stetler-Stevenson W, Liotta LA, Birkedal-Hansen H, Mann W, Furie M. Zucker S, et al. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):475-9. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1302560

10

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.

Zucker S, Cao J, Chen WT. Zucker S, et al. Oncogene. 2000 Dec 27;19(56):6642-50. doi: 10.1038/sj.onc.1204097. Oncogene. 2000. PMID: 11426650 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters